Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GeneFormatics
AddedFeb 17, 2024
UpdatedJun 18, 2026
GeneFormatics

GeneFormatics

Closed

GeneFormatics: A leading biotech company specializing in structural proteomics.

HQ
San Diego, CA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

GeneFormatics, founded with a mission to advance the field of structural proteomics, is a biotechnology company focused on understanding protein structures to drive innovation in drug discovery and development. The company's vision is to leverage cutting-edge technology to decode the complexities of protein structures, thereby facilitating the creation of more effective therapeutics. GeneFormatics offers specialized services in protein structure determination and analysis, catering primarily to pharmaceutical companies and research institutions.

Notable figures associated with GeneFormatics include leading scientists and industry experts in the field of proteomics. The company has attracted significant investment from prominent venture capital firms specializing in biotech. Key achievements include pioneering advancements in structural proteomics techniques and contributing to several high-impact research publications. GeneFormatics has made a substantial impact by accelerating the drug discovery process and enhancing the understanding of complex biological systems.

GeneFormatics - Similar Companies

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Geneformics logo

Geneformics

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Flexomics logo

Flexomics

flexomics.com

Geneicd logo

Geneicd

TigerGene logo

TigerGene

GeneCentrix logo

GeneCentrix

genecentrix.com

Sequegenics logo

Sequegenics

sequegenics.com

eBioinformatics logo

eBioinformatics

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Biotechonomy logo

Biotechonomy

Unite Genomics logo

Unite Genomics

Virogenomics logo

Virogenomics

virogenomics.com

NEO Proteomics logo

NEO Proteomics

neoproteomics.net

BioDatomics logo

BioDatomics

biodatomics.com

GeneFormatics - Quick Facts

Who are GeneFormatics' competitors?

Companies similar to GeneFormatics include Bioinformatics, Geneformics, Glyphic Biotechnologies and Flexomics.

When was GeneFormatics founded?

GeneFormatics was founded in 1998.

Where is GeneFormatics' headquarters located?

GeneFormatics' headquarters is located in San Diego, CA, US.

When was GeneFormatics' last funding round?

GeneFormatics' most recent funding round was for $24M (USD) in December 2002.

How much has GeneFormatics raised to-date?

As of Dec 6, 2002, GeneFormatics has raised a total of $46M (USD).

GeneFormatics - Classification

Industry
  • Professional Service Companies
Ownership
  • Equity
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Biotech
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software